
APALUTAMIDE 60 mg, an anti-androgen medication used in the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostate cancer (mCSPC).
| Generic Name | Apalutamide |
| Manufacturer | Natco Pharma Ltd |
| Packing | 120 Tablets |
| Prescribed For | Prostate Cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




| Package | USD | GBP | AUD | NZD | PHP | KRW | RON | HKD | MYR | THB | AED |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 120 Tablets | $435 | £326 | A$653 | NZ$718 | ₱24,708 | ₩585,075 | lei 1,871 | HK$3,393 | RM1,805 | ฿13,833 | د.إ1,596 |
Apalutamide prices may vary between countries depending on the brand, dosage form, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement or medicine information.
Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.